Financial Performance - The company reported a net loss attributable to shareholders of 56,551,531.55 yuan for the year 2024, with the parent company recording a net loss of 45,353,831.06 yuan[7]. - The company's operating revenue for 2024 was CNY 277,618,726.54, a decrease of 20.92% compared to CNY 351,076,211.54 in 2023[24]. - The net profit attributable to shareholders for 2024 was a loss of CNY 56,551,531.55, representing a decline of 309.69% from a profit of CNY 26,969,532.97 in 2023[24]. - Basic and diluted earnings per share for 2024 were both -CNY 0.56, reflecting a 300% decline from CNY 0.28 in 2023[25]. - The company's net assets attributable to shareholders decreased by 6.97% to CNY 834,367,357.99 at the end of 2024, compared to CNY 896,893,683.89 at the end of 2023[24]. - The company has not achieved profitability since its listing[4]. - The company recorded a non-operating income of 3.12 million yuan, significantly lower than the previous year's 65.06 million yuan[35]. - The company's investment income plummeted by 70.11% to ¥657,274, mainly due to reduced returns from structured financial products[150]. Governance and Compliance - The board of directors has proposed not to distribute profits for the year 2024, which includes no cash dividends, no bonus shares, and no capital reserve conversion[7]. - The audit report issued by Da Xin Accounting Firm confirmed the financial statements as true, accurate, and complete[6]. - The company has not engaged in any non-operating fund occupation by controlling shareholders or related parties[9]. - There are no violations of decision-making procedures regarding external guarantees[11]. - The company has not reported any special arrangements in corporate governance[9]. - All board members attended the board meeting, ensuring collective decision-making[5]. - The company held one annual and one extraordinary shareholders' meeting in 2024, ensuring compliance with relevant laws and regulations[198]. Risks and Challenges - The company has described potential risks in the report, which investors should be aware of when considering future investments[4]. - The report includes a forward-looking statement risk declaration, indicating that future plans do not constitute a commitment to investors[8]. - The company faces risks related to industry downturns and increased competition, which could negatively impact production and operations if demand decreases[130]. - The company faces risks related to the mismatch between new production capacity and market expansion[134]. Research and Development - The company has developed a core technology system for organic residue microbial solid-state fermentation, which has received multiple awards including the second prize for scientific and technological progress in Sichuan Province[24]. - The company has increased its R&D team to 51 members, accounting for 8.95% of the total workforce, with a focus on enhancing technical capabilities in synthetic biology and enzyme engineering[52]. - Research and development (R&D) expenses amounted to ¥19,759,033.83, representing a 44.70% increase compared to the previous year[112]. - R&D expenses accounted for 7.12% of total revenue, an increase of 3.23 percentage points from the previous year[112]. - The company has published two SCI papers on enzyme engineering and fermentation technology, showcasing its advancements in research and development[54]. - The company is leveraging AI technology to innovate in enzyme modification, significantly improving the efficiency of biological conversion processes[98]. - The company is focusing on the development of new feed based on microbial engineering to ensure food security and achieve agricultural carbon neutrality[101]. Market and Product Development - The company is focused on expanding its market presence and enhancing its product offerings, including functional feed materials derived from organic waste[24]. - The company achieved operating revenue of CNY 277.62 million, a decrease of 20.92% compared to the same period last year[26]. - The sales volume of the company's liquor lees biological fermentation feed business reached 112,600 tons, an increase of 20.74% year-on-year, with sales revenue of CNY 216.85 million, up 10.19% year-on-year[26]. - The revenue from the biological fermentation feed business was 216.85 million yuan, an increase of 10.19%, accounting for 78.11% of total operating revenue[43]. - The company plans to enhance the scale effect of its liquor lees biological fermentation feed business as new projects are put into operation, which is expected to gradually reduce the impact of period expenses on profits[30]. - The company has developed innovative products such as "善水路德®酵肽" and "蔺福®" series, enhancing nutritional and functional components for animal feed while addressing environmental concerns[63]. - The company is actively pursuing new strategies for growth, including potential mergers and acquisitions to enhance its technological capabilities and market reach[24]. Environmental and Sustainability Initiatives - The company is committed to reducing antibiotic usage by 30-50% and lowering nitrogen and phosphorus emissions through its microbial fermentation technology[99]. - The company’s fermentation feed services align with national policies focused on sustainable growth and environmental protection, supporting the circular economy in the liquor industry[75]. - The company has developed a technology for the resource utilization of high-concentration brewing wastewater, producing liquid fermentation feed while addressing high treatment costs and environmental concerns[76]. - The company is focused on the high-value utilization of brewing by-products, with ongoing projects aimed at producing γ-PGA and GABA, which are expected to fill domestic production gaps[117]. - The company aims to enhance its market share and brand image by focusing on biomanufacturing and expanding its production capacity in the coming years[92]. Financial Management and Strategy - The company has implemented strict cost control measures, including long-term agreements with liquor companies to stabilize procurement costs[128]. - The company has enhanced its accounts receivable management by linking collection efforts to departmental performance evaluations, improving cash flow efficiency[57]. - The company will implement a centralized budget management system to optimize operational costs and ensure stable cash flow[193]. - The company plans to invest in projects that convert organic waste (such as liquor dregs) into fermentation feed through biotechnology, leveraging policy benefits[184]. - The company aims to integrate the liquor industry with the breeding industry, creating an innovative industrial chain model focused on high-value utilization of brewing waste[184].

Financial Performance - The company's revenue for Q1 2025 was CNY 63.07 million, a decrease of 7.18% compared to the same period last year[3]. - Net profit attributable to shareholders was CNY 1.25 million, down 77.89% year-on-year, while the net profit after deducting non-recurring gains and losses was CNY 0.72 million, a decrease of 85.75%[5]. - The cash flow from operating activities was CNY 9.46 million, a decline of 72.10% compared to the previous year[3]. - Total revenue for Q1 2025 was CNY 63,074,491.09, a decrease of 7.5% compared to CNY 67,954,689.05 in Q1 2024[19]. - Operating profit for Q1 2025 was a loss of CNY 3,558,033.24, compared to a profit of CNY 4,506,061.18 in Q1 2024[20]. - Net profit for Q1 2025 was CNY 213,477.84, significantly down from CNY 4,072,055.93 in Q1 2024[20]. - The company reported a significant increase in financial expenses, with interest expenses rising to CNY 4,921,381.45 from CNY 2,491,696.45 year-over-year[19]. - Basic and diluted earnings per share were both ¥0.01, down from ¥0.06 in the previous year[21]. - The total comprehensive income attributable to the parent company was ¥1,254,440.92, compared to ¥5,673,773.52 in the previous period[21]. Assets and Liabilities - The company reported a total asset value of CNY 1.70 billion, a decrease of 1.73% from the end of the previous year[4]. - Total assets decreased to CNY 1,695,470,741.28 from CNY 1,725,397,885.37 year-over-year[18]. - Total liabilities decreased to CNY 802,384,692.71 from CNY 852,525,314.64 year-over-year[17]. - Current liabilities totaled CNY 450,538,735.26, down from CNY 540,351,071.06 in the previous year[17]. - Non-current liabilities increased to CNY 351,845,957.45 from CNY 312,174,243.58 year-over-year[17]. Cash Flow - The net cash flow from operating activities was -72.10 million RMB, attributed to decreased cash received from sales and increased salary and tax expenses[10]. - The net cash flow from investing activities was -33.16 million RMB, mainly due to reduced cash payments for fixed assets and other long-term assets[10]. - The net cash flow from financing activities was -84.62 million RMB, resulting from reduced bank loans and timely repayment of maturing loans[10]. - In Q1 2025, the company reported a net cash flow from operating activities of ¥9,457,776.71, a decrease of 72% compared to ¥33,903,191.43 in Q1 2024[23]. - Total cash inflow from operating activities was ¥106,635,040.51, down 25% from ¥142,027,261.14 in the previous year[23]. - The company experienced a significant decline in cash received from sales, totaling ¥70,739,702.15, which is a 36% decrease from ¥109,982,009.24 in Q1 2024[23]. - The net cash flow from investing activities was -¥88,268,459.07, an improvement from -¥132,056,910.68 in Q1 2024[24]. - Cash inflow from financing activities was ¥88,974,000.00, a decrease of 39% from ¥147,170,000.00 in Q1 2024[25]. - The ending cash and cash equivalents balance was ¥147,088,067.86, down from ¥183,280,770.50 in Q1 2024[25]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 3,090[12]. - The largest shareholder, Ji Guangming, holds 27.70% of the shares, totaling 27,897,730 shares[13]. - There were no changes in the participation of major shareholders in margin trading or securities lending activities[14]. Business Operations - Research and development expenses totaled CNY 2.21 million, down 32.85% year-on-year, accounting for 3.51% of revenue[4]. - The sales volume of the company's liquor lees fermentation feed business reached 27,500 tons, an increase of 12.16% year-on-year, but revenue from this segment decreased by 7.38% to CNY 46.61 million[5]. - Revenue from inorganic solid waste treatment services increased by 22.35% to CNY 13.33 million, recovering from a low operating rate in the previous year[5]. - The company plans to improve the gross margin of its liquor lees fermentation feed business by optimizing raw material procurement and increasing production capacity utilization[5]. - The company experienced a decline in gross profit margin in its liquor residue fermentation feed business due to price adjustments and industry factors[10]. - The company has not disclosed any significant new strategies or product developments during the reporting period[15].

路德生物环保科技股份有限公司 证券代码：688156 证券简称：路德环境 公告编号：2025-007 路德生物环保科技股份有限公司 关于 2024 年度拟不进行利润分配的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次拟不进行利润分配的预案已经公司第四届董事会第二十三次会议、 第四届监事会第十九次会议审议通过，尚需提交公司 2024 年年度股东大会审议。 公司不触及《上海证券交易所科创板股票上市规则》（以下简称"《股 票上市规则》"）第 12.9.1 条第一款第（八）项规定的可能被实施其他风险警 示的情形。 一、2024 年度利润分配方案基本情况 （一）利润分配方案的具体内容 经大信会计师事务所（特殊普通合伙）审计，公司 2024 年度实现归属于上 市公司股东的净利润为-56,551,531.55 元，母公司实现净利润-45,353,831.06 元。截至 2024 年 12 月 31 日，公司合并报表未分配利润为 137,202,171.22 元， 母公司未分配利润为 92,198,965.12 ...

路德环境公告，2025年第一季度营业收入6307.45万元，同比下降7.18%。净利润125.44万元，同比下降 77.89%。 ...

路德环境公告，2024年营业收入为2.78亿元，同比下降20.92%。归属于上市公司股东的净亏损5655.15 万元，去年同期净利润2696.95万元。公司2024年度拟不进行利润分配，不派发现金红利，不送红股， 不以资本公积转增股本和其他形式的分配。 ...

国投证券股份有限公司 关于路德生物环保科技股份有限公司 部分募投项目结项及部分募投项目延期的核查意见 国投证券股份有限公司（以下简称"国投证券"或"保荐机构"，曾用名为 安信证券股份有限公司）作为路德生物环保科技股份有限公司（简称"路德环境" 或"公司"）的保荐机构和持续督导机构，根据《上市公司监管指引第2号—— 上市公司募集资金管理和使用的监管要求》《上海证券交易所上市公司自律监管 指引第1号——规范运作》《上海证券交易所科创板股票上市规则》等相关规定， 对路德环境部分募投项目结项及部分募投项目延期事项进行审慎核查，具体核查 情况和核查意见如下： 一、募集资金基本情况 （一）募集资金金额及到账时间 经中国证券监督管理委员会《关于同意路德环境科技股份有限公司首次公开 发行股票注册的批复》（证监许可[2020]1915 号）核准，并经上海证券交易所同 意，公司首次向社会公开发行人民币普通股股票 2,296 万股，发行价格为每股 15.91 元，募集资金总额为 36,529.36 万元，根据相关规定扣除发行费用 4,111.88 万元后实际募集资金净额为 32,417.48 万元。其中，保荐承销费用为 2,922 ...

4月8日，路德环境(688156)股价强势涨停，收盘报14.39元/股，涨幅达20%，日振幅值达19.27%，日换 手率9.57%，成交额1.34亿元，总市值升至14.49亿元。 为把握政策机遇，路德环境加速布局产能，先后建成投产了5个白酒糟生物发酵饲料工厂，包括古蔺路 德、金沙路德、亳州路德、遵义路德、永乐路德。目前公司白酒糟生物发酵饲料业务总产能达到52万 吨。 针对市场波动，路德环境相关负责人向证券时报记者表示，近期美国政府加征"对等关税"政策可能推高 大豆远期价格，而公司研发的白酒糟生物发酵饲料产品可有效替代豆粕和玉米，既符合国家节粮政策导 向，又为粮食安全提供保障。 2024年12月，路德环境连续发布公告，遵义路德引入湖北农发饲料有限公司作为战略股东，农发饲料将 以现金方式向遵义路德增资并签订长期生物发酵饲料大额采购订单；金沙路德引入贵州省生态环保发展 股权投资基金3200万元增资，进一步加码产能建设。 当日，沪深交易所公布的龙虎榜数据显示，路德环境因单日涨幅超过15%上榜，总买入额3861.10万 元，总卖出额3128.28万元，总净买732.82万元。 路德环境相关负责人表示，随着项目的陆续建成 ...

路德环境688156 元 当日主力成本 12.68 元 时间: 2025年3月31日星期一 36.71分综合得分 偏弱 趋势方向 主力成本分析 12.42 5日主力成本 13.36 元 20日主力成本 13.49 元 60日主力成本 周期内涨跌停 过去一年内该股 涨停 0次 跌停 0 次 技术面分析 12.87 短期压力位 12.68 短期支撑位 14.26 中期压力位 12.68 中期支撑位 股价跌破短期支撑位，短线观望为宜； 股价跌破中期支撑位，中期主力资金做多意愿不强，以观望为 宜 K线形态 ★三只乌鸦★ 可能见顶回落 资金流数据 2025年03月31日的资金流向数据方面 | 主力资金净流入99.19万元 | | --- | | 占总成交额8% | | 超大单净流入0.00元 | | 大单净流入99.19万元 | | 散户资金净流出177.83万 | 关联行业/概念板块 农牧饲渔 -1.30%、生态农业 -1.61%、节能环保 -1.07%、微盘股 -1.13%等 财务数据 99.19万; 8%; 0.00; 99.19万元; 177.83万; 北向资金数据：暂无。 | 每股收益-0.03元 | 营业利 ...

路德生物环保科技股份有限公司 证券代码：688156 证券简称：路德环境 公告编号：2025-003 路德生物环保科技股份有限公司 关于合伙企业变更执行事务合伙人暨持股 5%以上股 东权益变动的提示性公告 一、信息披露义务人基本情况 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次权益变动系路德生物环保科技股份有限公司（以下简称"公司"） 实际控制人与部分一致行动人解除一致行动关系，不涉及各方实际持股数量的增 减，亦不触及要约收购。 季光明先生为公司控股股东、实际控制人，白彩群女士为季光明先生之 妻妹。本次权益变动前，季光明先生担任武汉德天众享企业管理合伙企业（有限 合伙）（以下简称"德天众享"）的执行事务合伙人，季光明先生、白彩群女士 及德天众享构成一致行动关系，合计持有公司 29,968,730 股，占公司总股本的 比例为 29.76%。 鉴于德天众享的执行事务合伙人已由季光明先生变更为周雨林先生，德 天众享与公司实际控制人的一致行动关系解除。本次权益变动后，季光明先生、 白彩群女士为一致行动人，合 ...

Financial Performance - The total operating revenue for the reporting period was RMB 282.10 million, a decrease of 19.65% compared to the same period last year[3] - The net profit attributable to the parent company was -RMB 56.93 million, a decline of 311.10% year-on-year[3] - The basic earnings per share fell to -RMB 0.57, a decrease of 303.57% compared to the previous year[3] - The net profit attributable to the parent company after deducting non-recurring gains and losses was -RMB 59.83 million, a decline of 392.36% year-on-year[3] Assets and Equity - The total assets at the end of the reporting period were RMB 1,732.48 million, an increase of 9% from the beginning of the period[5] - The equity attributable to the parent company decreased by 7.01% to RMB 833.99 million[5] Business Operations - The company adjusted its business structure, leading to a significant decline in revenue from inorganic solid waste treatment services due to not undertaking new environmental projects[6] - The company experienced an increase in research and development, sales, management, and financial expenses due to capacity expansion in the white wine residue fermentation feed business[6] Profitability and Margins - The gross profit margin decreased due to falling prices of feed raw materials and overall adjustments in the livestock industry[5] - The company reported an increase in credit impairment losses and asset impairment losses compared to the previous year[8]